Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Hematologic Disease
Researchers' work from Ege University, Medical Department focuses on hematologic disease
April 29th, 2008
"The goat of this study was to conduct an accelerated vaccination program and to determine its efficacy in patients susceptible to hepatitis B virus (HBV) receiving chemotherapy because of their hematologic malignancies. Over a one-year period, a total of 327 patients who were diagnosed as having a hematologic malignancy were serologically analyzed in terms of HBV infection," researchers in Izmir, Turkey report. "Of those found to be susceptible to HBV infection, a total of 42 patients consisting of 16 females and 26 mates were enrolled in the accelerated vaccination program. All the patients were administered a 20-mu g yeast-derived recombinant hepatitis B vaccine on...
Source: Cancer Weekly (2008-04-29)
|
